Breaking News
0

Obalon Therapeutics Inc (OBLN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Obalon Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.80 +0.00    +0.00%
18/10 - Closed. Currency in USD ( Disclaimer )
After Hours
1.80
0.00
0.00%
19:12:09 - Real-time Data
Type: Equity
Market: United States
ISIN: US67424L2097 
CUSIP: 67424L209
  • Volume: 276,676
  • Bid/Ask: 1.69 / 1.80
  • Day's Range: 1.71 - 1.81
Start Trading
| AD |
Obalon Therapeutics 1.80 +0.00 +0.00%
Start Trading
| AD |

Obalon Therapeutics Inc Company Profile

 
Get an in-depth profile of Obalon Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryMedical Equipment & Supplies
SectorHealthcare
Employees

100

Equity Type

ORD

Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in obese patients. The Obalon balloon system is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. All balloons must be removed six months after the first balloon is placed. The Obalon balloon system intends to provide patients and physicians with a reversible and repeatable weight loss solution in an outpatient setting, without altering patient anatomy or requiring surgery. The Company has received Premarket approval (PMA) for its Obalon balloon system based on the results of its United States pivotal clinical trial, referred to as the SMART trial.

Contact Information

Phone +1-858-4802400
Fax 302-6365454

Top Executives

Name Age Since Title
Andrew P. Rasdal 53 2019 Chairman of the Board
Nooshin Hussainy 58 2011 Vice President - Finance
Sharon Stevenson 67 2008 Independent Director
Lesley H Howe 73 2016 Independent Director
Douglas Fisher 40 2012 Independent Director
David Moatazedi 41 2017 Director
Raymond V. Dittamore 73 2016 Independent Director
Bob MacDonald - 2019 Chief Retail Officer
Amy VandenBerg 41 2019 Chief Clinical and Regulatory Affairs Officer
Mark Brister 53 2008 Vice President - Research & Development
Steve Johnson 59 2014 Vice President - Operations
Todd Wood - 2018 Vice President - Global Sales
Donald Young 58 2016 Vice President of Quality Assurance
Lisa Metzner 47 2016 Vice President of Marketing
Matthew Norwood 41 2016 Vice President of Sales
William J. Plovanic 47 2019 President, Chief Financial Officer
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

OBLN Comments

Write your thoughts about Obalon Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Dosbol Sheryazov
Dosbol Sheryazov Jul 31, 2019 5:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
shares can rise to 15?
Dosbol Sheryazov
Dosbol Sheryazov Jul 31, 2019 5:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Stocks can be up to 15?
Trader Canarias
Trader Canarias Jul 25, 2019 9:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sell at.....5.33
Brian Schec
Brian Schec Jul 25, 2019 8:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
+900% premarket? That’s the reverse stock split.
Matthew Randolph
Matthew Randolph Jul 25, 2019 8:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
their earnings date was yesterday. I was trying to buy this yesterday at 3pm when it was .60 ..
matthew sprinkle
matthew sprinkle Jul 11, 2019 1:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
debt is fixed patent is coming up volume has sky rocketed
Trader Canarias
Trader Canarias May 30, 2019 8:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
exclusive provider.....that is against the law
lee hine
lee hine May 30, 2019 8:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What you on  about
lee hine
lee hine May 30, 2019 8:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Debt to Equity ratio is off the chart
lee hine
lee hine May 30, 2019 6:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Premarket pump and dump
Perren Vann
SMALLDUDE May 29, 2019 11:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
alerted, https://www.onebytemedia.com/alert-new-symbols-obln-eltk-were-added-to-afterhour-watchlist/
Daniel Kawa
Daniel Kawa May 29, 2019 10:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
8$ bid from JJ. @ 0.77/share
Adam Garbin
Adam Garbin May 07, 2019 10:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Obln just signed to be the exclusive provider for insulin for medicare and medicaid... in about a month or so, this will be the only insulin for a great majority of the US population... notices have already been handed out in nursing homes advising residents of this change.
Grim Stock
Grim Stock May 07, 2019 10:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
gastric balloon company, I don't think they deal in insulin
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email